Century Therapeutics (IPSC) Total Debt (2020 - 2026)

Century Therapeutics (IPSC) has 6 years of Total Debt data on file, last reported at $1.9 million in Q1 2026.

• Total Debt for Q1 2026 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (changed N/A YoY), and the FY2025 annual result was $3.8 million, changed N/A from the prior year.
• Total Debt retreated to $1.9 million in Q1 2026 per IPSC's latest filing, from $3.8 million in the prior quarter.
• Over five years, Total Debt peaked at $10.3 million in Q1 2023 and troughed at $1.9 million in Q1 2026.
• A 4-year average of $8.1 million and a median of $10.1 million in 2022 frame the typical range for Total Debt.
• The sharpest annual moves came in 2022 and 2023: Total Debt advanced 3.01% in 2022, then advanced 2.78% in 2023.
• A 4-year view of Total Debt shows it stood at $10.2 million in 2022, then increased by 0.55% to $10.3 million in 2023, then tumbled by 63.51% to $3.8 million in 2025, then sank by 48.39% to $1.9 million in 2026.
• Business Quant data shows IPSC's Total Debt at $1.9 million in Q1 2026, $3.8 million in Q4 2025, and $8.3 million in Q3 2025.